78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Edwards Lifesciences's debt to equity ratio is 0.06: total debt of 704.50M USD against shareholders' equity of 10.86B USD.
- Today
- 0.06
- Average, 5 years
- 0.09
- Low, 5 years
- 0.06
- High, 5 years
- 0.12
Debt to equity = total debt ÷ shareholders' equity = 704.50M ÷ 10.86B = 0.06
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.06 | 704.50M | 10.86B | |
| FY2025 | 31 Dec 2025 | 0.07 | 705.40M | 10.34B |
| FY2024 | 31 Dec 2024 | 0.07 | 700.00M | 10.00B |
| FY2023 | 31 Dec 2023 | 0.10 | 685.10M | 6.65B |
| FY2022 | 31 Dec 2022 | 0.12 | 691.30M | 5.81B |
| FY2021 | 31 Dec 2021 | 0.12 | 690.30M | 5.84B |
| FY2020 | 31 Dec 2020 | 0.15 | 694.90M | 4.57B |
| FY2019 | 31 Dec 2019 | 0.16 | 678.80M | 4.15B |
| FY2018 | 31 Dec 2018 | 0.19 | 593.80M | 3.14B |
| FY2017 | 31 Dec 2017 | 0.35 | 1.04B | 2.99B |
| FY2016 | 31 Dec 2016 | 0.31 | 822.30M | 2.62B |
| FY2015 | 31 Dec 2015 | 0.24 | 596.90M | 2.50B |
| FY2014 | 31 Dec 2014 | 0.27 | 598.10M | 2.19B |
| FY2013 | 31 Dec 2013 | 0.38 | 593.10M | 1.56B |
| FY2012 | 31 Dec 2012 | 0.13 | 189.30M | 1.48B |
| FY2011 | 31 Dec 2011 | 0.11 | 150.40M | 1.34B |
| FY2010 | 31 Dec 2010 | 0.03 | 41.80M | 1.31B |
| FY2009 | 31 Dec 2009 | 0.08 | 90.30M | 1.16B |
| FY2008 | 31 Dec 2008 | 0.20 | 175.50M | 878.80M |
| FY2007 | 31 Dec 2007 | 0.25 | 211.70M | 835.00M |
| FY2006 | 31 Dec 2006 | 0.31 | 235.90M | 749.40M |
| FY2005 | 31 Dec 2005 | 0.46 | 316.10M | 690.00M |
| FY2004 | 31 Dec 2004 | 0.43 | 267.10M | 628.10M |
| FY2003 | 31 Dec 2003 | 0.40 | 255.80M | 635.10M |
| FY2002 | 31 Dec 2002 | 0.46 | 245.50M | 539.40M |
| FY2001 | 31 Dec 2001 | 0.68 | 310.90M | 459.00M |
| FY2000 | 31 Dec 2000 | 0.97 | 428.00M | 440.00M |
| FY1999 | 31 Dec 1999 | 0.00 | 0.00 | 1.22B |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.06 | 704.50M | 10.86B |
| Q2 FY2026 | 30 Jun 2026 | 0.07 | 704.40M | 10.62B |
| Q1 FY2026 | 31 Mar 2026 | 0.07 | 702.90M | 10.33B |
| Q4 FY2025 | 31 Dec 2025 | 0.07 | 705.40M | 10.34B |
| Q3 FY2025 | 30 Sept 2025 | 0.07 | 700.30M | 10.21B |
| Q2 FY2025 | 30 Jun 2025 | 0.07 | 702.60M | 10.55B |
| Q1 FY2025 | 31 Mar 2025 | 0.07 | 699.40M | 10.13B |
| Q4 FY2024 | 31 Dec 2024 | 0.07 | 700.00M | 10.00B |
| Q3 FY2024 | 30 Sept 2024 | 0.07 | 706.70M | 9.55B |
| Q2 FY2024 | 30 Jun 2024 | 0.09 | 693.00M | 7.44B |
| Q1 FY2024 | 31 Mar 2024 | 0.10 | 699.20M | 7.12B |
| Q4 FY2023 | 31 Dec 2023 | 0.10 | 685.10M | 6.65B |
| Q3 FY2023 | 30 Sept 2023 | 0.10 | 691.10M | 6.66B |
| Q2 FY2023 | 30 Jun 2023 | 0.11 | 684.50M | 6.38B |
| Q1 FY2023 | 31 Mar 2023 | 0.12 | 687.80M | 5.98B |
| Q4 FY2022 | 31 Dec 2022 | 0.12 | 691.30M | 5.81B |
| Q3 FY2022 | 30 Sept 2022 | 0.11 | 686.80M | 6.22B |
| Q2 FY2022 | 30 Jun 2022 | 0.11 | 682.80M | 5.94B |
| Q1 FY2022 | 31 Mar 2022 | 0.12 | 688.20M | 5.84B |
| Q4 FY2021 | 31 Dec 2021 | 0.12 | 690.30M | 5.84B |
| Q3 FY2021 | 30 Sept 2021 | 0.12 | 684.10M | 5.54B |
| Q2 FY2021 | 30 Jun 2021 | 0.13 | 684.20M | 5.13B |
| Q1 FY2021 | 31 Mar 2021 | 0.15 | 688.80M | 4.66B |
| Q4 FY2020 | 31 Dec 2020 | 0.15 | 694.90M | 4.57B |
| Q3 FY2020 | 30 Sept 2020 | 0.16 | 690.10M | 4.21B |
| Q2 FY2020 | 30 Jun 2020 | 0.18 | 684.50M | 3.84B |
| Q1 FY2020 | 31 Mar 2020 | 0.17 | 675.20M | 3.90B |
| Q4 FY2019 | 31 Dec 2019 | 0.16 | 678.80M | 4.15B |
| Q3 FY2019 | 30 Sept 2019 | 0.18 | 670.70M | 3.81B |
| Q2 FY2019 | 30 Jun 2019 | 0.19 | 668.30M | 3.50B |
| Q1 FY2019 | 31 Mar 2019 | 0.19 | 666.20M | 3.45B |
| Q4 FY2018 | 31 Dec 2018 | 0.19 | 593.80M | 3.14B |
| Q3 FY2018 | 30 Sept 2018 | 0.36 | 1.19B | 3.36B |
| Q2 FY2018 | 30 Jun 2018 | 0.38 | 1.19B | 3.16B |
| Q1 FY2018 | 31 Mar 2018 | 0.32 | 1.05B | 3.25B |
| Q4 FY2017 | 31 Dec 2017 | 0.35 | 1.04B | 2.99B |
| Q3 FY2017 | 30 Sept 2017 | 0.33 | 1.03B | 3.16B |
| Q2 FY2017 | 30 Jun 2017 | 0.35 | 1.02B | 2.94B |
| Q1 FY2017 | 31 Mar 2017 | 0.31 | 847.90M | 2.74B |
| Q4 FY2016 | 31 Dec 2016 | 0.31 | 822.30M | 2.62B |
| Q3 FY2016 | 30 Sept 2016 | 0.22 | 600.60M | 2.69B |
| Q2 FY2016 | 30 Jun 2016 | 0.24 | 602.50M | 2.47B |
| Q1 FY2016 | 31 Mar 2016 | 0.26 | 602.20M | 2.30B |
| Q4 FY2015 | 31 Dec 2015 | 0.24 | 596.90M | 2.50B |
| Q3 FY2015 | 30 Sept 2015 | 0.25 | 604.90M | 2.42B |
| Q2 FY2015 | 30 Jun 2015 | 0.26 | 600.30M | 2.29B |
| Q1 FY2015 | 31 Mar 2015 | 0.27 | 602.70M | 2.21B |
| Q4 FY2014 | 31 Dec 2014 | 0.27 | 598.10M | 2.19B |
| Q3 FY2014 | 30 Sept 2014 | 0.30 | 610.00M | 2.04B |
| Q2 FY2014 | 30 Jun 2014 | 0.31 | 598.00M | 1.91B |
| Q1 FY2014 | 31 Mar 2014 | 0.54 | 725.40M | 1.34B |
| Q4 FY2013 | 31 Dec 2013 | 0.38 | 593.10M | 1.56B |
| Q3 FY2013 | 30 Sept 2013 | 0.37 | 532.10M | 1.44B |
| Q2 FY2013 | 30 Jun 2013 | 0.14 | 227.30M | 1.58B |
| Q1 FY2013 | 31 Mar 2013 | 0.12 | 192.70M | 1.59B |
| Q4 FY2012 | 31 Dec 2012 | 0.13 | 189.30M | 1.48B |
| Q3 FY2012 | 30 Sept 2012 | 0.11 | 175.40M | 1.54B |
| Q2 FY2012 | 30 Jun 2012 | 0.13 | 185.10M | 1.43B |
| Q1 FY2012 | 31 Mar 2012 | 0.13 | 179.40M | 1.39B |
| Q4 FY2011 | 31 Dec 2011 | 0.11 | 150.40M | 1.34B |
| Q3 FY2011 | 30 Sept 2011 | 0.13 | 175.00M | 1.35B |
| Q2 FY2011 | 30 Jun 2011 | 0.13 | 174.80M | 1.39B |
| Q1 FY2011 | 31 Mar 2011 | 0.11 | 149.50M | 1.36B |
| Q4 FY2010 | 31 Dec 2010 | 0.03 | 41.80M | 1.31B |
| Q3 FY2010 | 30 Sept 2010 | 0.08 | 100.60M | 1.23B |
| Q2 FY2010 | 30 Jun 2010 | 0.16 | 177.50M | 1.12B |
| Q1 FY2010 | 31 Mar 2010 | 0.11 | 129.30M | 1.15B |
| Q4 FY2009 | 31 Dec 2009 | 0.08 | 90.30M | 1.16B |
| Q3 FY2009 | 30 Sept 2009 | 0.09 | 102.30M | 1.09B |
| Q2 FY2009 | 30 Jun 2009 | 0.11 | 113.90M | 1.00B |
| Q1 FY2009 | 31 Mar 2009 | 0.13 | 123.00M | 943.30M |
| Q4 FY2008 | 31 Dec 2008 | 0.20 | 175.50M | 878.80M |
| Q3 FY2008 | 30 Sept 2008 | 0.23 | 202.80M | 874.50M |
| Q2 FY2008 | 30 Jun 2008 | 0.16 | 141.70M | 897.30M |
| Q1 FY2008 | 31 Mar 2008 | 0.27 | 212.90M | 777.60M |
| Q4 FY2007 | 31 Dec 2007 | 0.25 | 211.70M | 835.00M |
| Q3 FY2007 | 30 Sept 2007 | 0.26 | 211.20M | 823.80M |
| Q2 FY2007 | 30 Jun 2007 | 0.26 | 207.60M | 807.50M |
| Q1 FY2007 | 31 Mar 2007 | 0.29 | 224.50M | 785.00M |
| Q4 FY2006 | 31 Dec 2006 | 0.31 | 235.90M | 749.40M |
| Q3 FY2006 | 30 Sept 2006 | 0.35 | 253.00M | 727.90M |
| Q2 FY2006 | 30 Jun 2006 | 0.39 | 279.60M | 722.40M |
| Q1 FY2006 | 31 Mar 2006 | 0.40 | 289.00M | 724.00M |
| Q4 FY2005 | 31 Dec 2005 | 0.46 | 316.10M | 690.00M |
| Q3 FY2005 | 30 Sept 2005 | 0.38 | 251.50M | 659.20M |
| Q2 FY2005 | 30 Jun 2005 | 0.41 | 269.60M | 661.70M |
| Q1 FY2005 | 31 Mar 2005 | 0.43 | 275.80M | 648.10M |
| Q4 FY2004 | 31 Dec 2004 | 0.43 | 267.10M | 628.10M |
| Q3 FY2004 | 30 Sept 2004 | 0.45 | 269.20M | 599.30M |
| Q2 FY2004 | 30 Jun 2004 | 0.53 | 312.80M | 586.20M |
| Q1 FY2004 | 31 Mar 2004 | 0.59 | 334.50M | 570.20M |
| Q4 FY2003 | 31 Dec 2003 | 0.40 | 255.80M | 635.10M |
| Q3 FY2003 | 30 Sept 2003 | 0.51 | 293.10M | 578.70M |
| Q2 FY2003 | 30 Jun 2003 | 0.55 | 307.30M | 559.00M |
| Q1 FY2003 | 31 Mar 2003 | 0.51 | 276.90M | 543.00M |
| Q4 FY2002 | 31 Dec 2002 | 0.46 | 245.50M | 539.40M |
| Q3 FY2002 | 30 Sept 2002 | 0.61 | 279.90M | 458.80M |
| Q2 FY2002 | 30 Jun 2002 | 0.62 | 297.50M | 479.60M |
| Q1 FY2002 | 31 Mar 2002 | 0.60 | 292.30M | 486.30M |
| Q4 FY2001 | 31 Dec 2001 | 0.68 | 310.90M | 459.00M |
| Q3 FY2001 | 30 Sept 2001 | 0.82 | 339.30M | 412.60M |
| Q2 FY2001 | 30 Jun 2001 | 0.93 | 388.20M | 415.70M |
| Q1 FY2001 | 31 Mar 2001 | 0.89 | 414.40M | 464.00M |
| Q4 FY2000 | 31 Dec 2000 | 0.97 | 428.00M | 440.00M |
| Q3 FY2000 | 30 Sept 2000 | 1.18 | 498.80M | 424.40M |
| Q2 FY2000 | 30 Jun 2000 | 1.29 | 531.00M | 411.00M |
| Q1 FY2000 | 31 Mar 2000 | 0.77 | 529.00M | 683.00M |
| Q4 FY1999 | 31 Dec 1999 | 0.00 | 0.00 | 1.22B |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about Edwards Lifesciences's debt to equity
Source: Financial Modeling Prep